Investment
Features
FeesSafety
Academy
More
Pluang+

Hawkins, Inc. posts record Q1 revenue of $315.7M with 8% growth, despite slight EPS dip.

Company Fundamentals
29 Jul 2026
GlobeNewsWire
View Source
Bullish
Hawkins, Inc. posts record Q1 revenue of $315.7M with 8% growth, despite slight EPS dip.

Hawkins, Inc. reported record first quarter fiscal 2027 revenue of $315.7 million, an 8% increase driven by growth across all segments: Water Treatment (6%), Food & Health Sciences (9%), and Industrial Solutions (10%). Despite a 4% decrease in diluted EPS to $1.35 and a 3% drop in net income to $28.3 million, the company achieved record gross profit and adjusted EBITDA. Hawkins also generated strong free cash flow, which funded stock repurchases, dividends, and the acquisition of Aqua-Chem, supporting its growth strategy. The company expects stabilized raw material costs and plans continued debt reduction and strategic investments in higher-margin businesses.

More News

UNFI Q4 revenue dips 1.6% but EPS rebounds to $0.61-$0.62, signaling strong profit recovery

UNFI Q4 revenue dips 1.6% but EPS rebounds to $0.61-$0.62, signaling strong profit recovery

United Natural Foods (UNFI) is set to report Q4 earnings with revenue expected around $7.71 billion, a slight 1.6% decline from last year due to network optimization. Despite the revenue drop, EPS is forecasted to rise sharply to $0.61-$0.62, a signi...

Company Fundamentals
Bullish
1 hour ago
Oracle's strong financials and AI investments boost analyst price target by 36%.

Oracle's strong financials and AI investments boost analyst price target by 36%.

Oracle reported strong fiscal 2026 results with 17% revenue growth to $67 billion and a 36% net income increase, driven by a 75% surge in its cloud infrastructure segment. Despite a recent 55% stock price drop from its peak, Morgan Stanley raised Ora...

Analyst Insights
Bullish
1 hour ago
RBC Capital raises Zscaler price target to $210 on strong revenue growth and AI-driven innovation.

RBC Capital raises Zscaler price target to $210 on strong revenue growth and AI-driven innovation.

RBC Capital increased its price target for cybersecurity firm Zscaler to $210, maintaining an "Outperform" rating due to the company's strong financial results and AI innovation. Zscaler reported a 25% rise in revenue and Annual Recurring Revenue, su...

Analyst Insights
Bullish
2 hours ago
Lululemon shares drop 18% as company cuts full-year forecast amid sales decline.

Lululemon shares drop 18% as company cuts full-year forecast amid sales decline.

Lululemon Athletica's shares fell about 18% after the company lowered its full-year financial forecast for the second time, reflecting ongoing challenges. In Q2 2026, total net revenue dropped 4% to $2.40 billion, with a 10% fall in comparable sales ...

Company Fundamentals
Bearish
3 hours ago
Teva gains bullish momentum after positive celiac disease trial and UBS upgrades price target to $48

Teva gains bullish momentum after positive celiac disease trial and UBS upgrades price target to $48

Teva Pharmaceutical Industries received a boost as UBS reaffirmed its "Buy" rating and raised the price target to $48, up from $36.62. This follows positive Phase 2a clinical trial results for TEV '408, a drug showing significant prevention of intest...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App